| Literature DB >> 31980123 |
Georgia M Davis1, Rodolfo J Galindo1, Alexandra L Migdal1, Guillermo E Umpierrez2.
Abstract
In past decades, a rapid evolution of diabetes technology led to increased popularity and use of continuous glucose monitoring (CGM) and continuous subcutaneous insulin infusion (CSII) in the ambulatory setting for diabetes management, and recently, the artificial pancreas became available. Efforts to translate this technology to the hospital setting have shown accuracy and reliability of CGM, safety of CSII in appropriate populations, improvement of inpatient glycemic control with computerized glycemic management systems, and feasibility of inpatient CGM-CSII closed-loop systems. Several ongoing studies are focusing on continued translation of this technology to improve glycemic control and outcomes in hospitalized patients.Entities:
Keywords: Diabetes; Glycemic control; Hospital; Inpatient; Technology
Mesh:
Substances:
Year: 2020 PMID: 31980123 PMCID: PMC7453786 DOI: 10.1016/j.ecl.2019.11.002
Source DB: PubMed Journal: Endocrinol Metab Clin North Am ISSN: 0889-8529 Impact factor: 4.741